Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free BOLT Stock Alerts

Bolt Biotherapeutics (BOLT) Institutional Ownership

Bolt Biotherapeutics logo
$3.92 +0.07 (+1.82%)
As of 03:59 PM Eastern
Compare

Institutional Ownership Changes (13F Filings) for Bolt Biotherapeutics (NASDAQ:BOLT)

Current
Institutional Ownership
Percentage
86.70%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$759.80K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$566.97K
Get BOLT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bolt Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BOLT Institutional Buying and Selling by Quarter

Bolt Biotherapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2026 Nan Fung Group Holdings Ltd5,000$19.25M0.0%N/A0.260%
5/14/2026 Renaissance Technologies LLC77,225$312K0.0%+40.3%4.022%
2/13/2026 Vivo Capital LLC72,414$396K0.0%-58.9%3.772%
2/12/2026 Renaissance Technologies LLC55,025$301K0.0%+92.2%2.866%
2/11/2026 T3 Companies LLC38,000$208K0.3%N/A1.979%
2/6/2026 Nano Cap New Millennium Growth Fund L P20,500$112K0.1%N/A1.068%
11/17/2025 Susquehanna International Group LLP16,642$89K0.0%N/A0.867%
11/14/2025 Shay Capital LLC15,958$85K0.0%N/A0.831%
11/14/2025 Squarepoint Ops LLC14,836$79K0.0%+19.8%0.773%
8/15/2025 Sofinnova Investments Inc.137,721$795K0.0%-95.0%7.173%
8/14/2025 Vivo Capital LLC176,064$986K0.1%-95.0%9.170%
8/14/2025 Nan Fung Group Holdings Ltd58,347$337K0.5%-95.0%3.039%
8/11/2025 Pfizer Inc31,305$181K0.0%-95.0%1.630%
8/8/2025 Geode Capital Management LLC18,533$108K0.0%-95.1%0.965%
7/31/2025 Board of Trustees of The Leland Stanford Junior University35,978$208K0.0%-95.0%1.874%
2/17/2025Velan Capital Investment Management LP50,000$27K0.0%N/A0.131%
2/17/2025Squarepoint Ops LLC48,971$26K0.0%N/A0.128%
2/17/2025Millennium Management LLC47,025$25K0.0%N/A0.123%
2/17/2025Citadel Advisors LLC78,961$42K0.0%N/A0.206%
11/16/2024Geode Capital Management LLC352,426$228K0.0%-5.0%0.921%
11/13/2024FMR LLC115,386$75K0.0%+33.2%0.302%
8/9/2024Renaissance Technologies LLC276,739$208K0.0%-46.5%0.726%
8/5/2024Acuitas Investments LLC630,507$473K0.3%+21.7%1.654%
7/18/2024Assenagon Asset Management S.A.34,488$26K0.0%N/A0.090%
2/15/2024Board of Trustees of The Leland Stanford Junior University719,546$806K0.1%-5.0%1.895%
2/7/2024Vivo Capital LLC3,521,291$3.94M0.3%-9.0%9.274%
11/14/2023Newtyn Management LLC1,020,000$1.06M0.3%+2.0%2.688%
7/26/2023Privium Fund Management B.V.116,516$148K0.0%N/A0.308%
7/25/2023Assenagon Asset Management S.A.158,289$203K0.0%-29.9%0.419%
5/8/2023Bailard Inc.28,500$40K0.0%N/A0.075%
2/15/2023Tang Capital Management LLC400,000$520K0.1%+100.0%1.062%
2/14/2023Susquehanna International Group LLP20,307$26K0.0%N/A0.054%
2/8/2023Russell Investments Group Ltd.40,195$52K0.0%-38.2%0.107%
1/12/2023Assenagon Asset Management S.A.225,816$294K0.0%-19.3%0.600%
1/12/2023Marquette Asset Management LLC97,835$127K0.0%+53.4%0.260%
11/15/2022Caas Capital Management LP116,777$173K0.0%N/A0.310%
11/14/2022RA Capital Management L.P.533,432$789K0.0%+18.5%1.417%
11/14/2022Ergoteles LLC88,174$130K0.0%-16.5%0.234%
11/4/2022Russell Investments Group Ltd.64,995$96K0.0%-32.4%0.173%
11/1/2022Privium Fund Management UK Ltd116,516$172K0.2%N/A0.310%
Someone just dumped the biggest gold fund. (Ad)

Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing total outflows to 14 billion. At the same time, the World Gold Council recorded the highest quarterly central bank gold buying on record, with buyers taking physical delivery instead of paper shares.tc pixel

Discover the company on the buying side before the September 30th delivery date.
10/18/2022Bailard Inc.46,383$69K0.0%N/A0.123%
7/29/2022Russell Investments Group Ltd.96,100$196K0.0%N/A0.256%
7/27/2022Assenagon Asset Management S.A.275,552$562K0.0%N/A0.735%
7/15/2022Marquette Asset Management LLC63,779$130K0.0%N/A0.170%
5/16/2022Echo Street Capital Management LLC123,804$5.49M0.0%N/A0.330%
5/11/2022GSA Capital Partners LLP54,038$148K0.0%N/A0.144%
5/9/2022Qube Research & Technologies Ltd19,611$54K0.0%-57.0%0.052%


BOLT Institutional Ownership - Frequently Asked Questions

During the previous two years, 16 institutional investors and hedge funds held shares of Bolt Biotherapeutics. The most heavily invested institutionals were Nan Fung Group Holdings Ltd ($19.25M), Sofinnova Investments Inc. ($795K), Vivo Capital LLC ($396K), Renaissance Technologies LLC ($312K), T3 Companies LLC ($208K), Board of Trustees of The Leland Stanford Junior University ($208K), and Pfizer Inc ($181K).Learn more on Bolt Biotherapeutics' institutional investors.

86.70% of Bolt Biotherapeutics' stock is owned by institutional investors. Learn more on BOLT's institutional investor holdings.

Of the 11 institutional investors that purchased Bolt Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Citadel Advisors LLC ($78.96K), Squarepoint Ops LLC ($51.42K), Velan Capital Investment Management LP ($50K), Renaissance Technologies LLC ($48.60K), Millennium Management LLC ($47.03K), T3 Companies LLC ($38K), and FMR LLC ($28.77K).

Institutional investors have bought a total of 147,148 shares in the last 24 months. This purchase volume represents approximately $759.80K in transactions.

The following institutional investors have sold Bolt Biotherapeutics stock in the last 24 months: Vivo Capital LLC ($103.65K).

Institutional investors have sold a total of 103,650 shares in the last 24 months. This volume of shares sold represents approximately $566.97K in transactions.


Related Companies

Institutional ownership data for NASDAQ:BOLT is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
Bezos… DOOMED
A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...
Paradigm Press | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Buy this stock today
Most tech companies skip dividends entirely. This one doesn't, paying shareholders like clockwork while flying...
Chaikin Analytics | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
Jeff Brown and Marc Chaikin's latest AI prediction explained
Jeff Brown and Marc Chaikin - the duo who identified Nvidia a decade ago - are forecasting that Elon Musk's AI...
Brownstone Research | Sponsoredtc pixel